5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid CAS:143382-03-0

Are you looking for trusted manufacturer or supplier of CAS:143382-03-0 5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid? Why not just drop an inquiry to info@nbinno.com or visit www.nbinno.com our official website?


5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid manufacturer in India China

CAS No: 143382-03-0
Product Name: 5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid
Other Name:
5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid
5-(Methoxymethyl)-2,3-pyridinedicarboxylic acid
 
Density: 1.4±0.1 g/cm3
Boiling Point: 428.6±45.0 °C at 760 mmHg
Molecular Formula: C9H9NO5
Molecular Weight: 211.171
Flash Point: 213.0±28.7 °C
Exact Mass: 211.048065
PSA: 96.72000
LogP: -1.70
Vapour Pressure: 0.0±1.1 mmHg at 25°C
Index of Refraction: 1.589
 
Specification
Appearance: Solid
Assay: ≥99.0%
Loss on drying: ≤0.5%
 
Application
intermediates of Imazamox CAS: 114311-32-9.
Be used as pesticide intermediates, mainly used to synthesize herbicide imazamox.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid Certificate of analysis (COA),5-(Methoxymethyl)-2,3-pyridinedicarboxylic acid Specification,5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid Safety Data Sheet (MSDS),5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid NMR,5-(Methoxymethyl)-2,3-pyridinedicarboxylic acid Route of synthesis (ROS),5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid Method of Anasis (MOA),5-(Methoxymethyl)pyridine-2,3-dicarboxylic acid manufacturers,5-(Methoxymethyl)-2,3-pyridinedicarboxylic acid suppliers,CAS 143382-03-0 manufacturers.


Related News: Today’s announcement is strongly aligned to IDA Ireland’s Regional pillar and its continued commitment to winning jobs and investment in regional locations. I wish Charles River every success with this expansion.”(2-Bromophenylcarbonyl)piperidine manufacturer “It’s truly an important scientific issue and important public health issue and FDA is actively exploring all regulatory options for providing access to additional doses of authorized vaccines in situations where data suggests the benefits would outweigh the risks,” Fink said.Methyl 3-(4-chlorophenyl)-3-oxopropanoate supplier However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. Dodecyl (9E)-9-octadecenoate producer.